Plant-based insulin moves forward
Canadian biotech company SemBioSys has signed a manufacturing deal with Cangene to process and purify its novel plant-derived insulin.
Canadian biotech company SemBioSys has signed a manufacturing deal with Cangene to process and purify its novel plant-derived insulin.
The growing inhaler device market is driving demand for automated quality control (QC) testing equipment for these products, according to Astech Projects.
Novo Nordisk is planning to sue the head of the US Patent and Trademark Office after its inhaled insulin product has had its patent application knocked back for the second time.
Scientists have discovered a new nanoparticule-based drug delivery system to treat brain cancer that it claims could revolutionise currently used chemotherapeutic treatments for this devastating type of cancer.